STOCK TITAN
  1. Home
  2. Sec-filings
  3. QDEL
  4. [Form 4] QuidelOrtho Corp Insider Trading Activity

QuidelOrtho (QDEL) director granted RSUs in lieu of board cash fees

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

QuidelOrtho Corp director Michael Edward L. received several equity-based compensation awards in the form of restricted stock units on June 25, 2026. These awards are structured as premium, converted, and equity grant restricted stock units, each representing the right to receive one share of QuidelOrtho common stock.

The grants were made at a price of $0.00 per unit as compensation rather than open-market purchases. Footnotes explain that one set of restricted stock units will vest on June 25, 2027, and another set vests in four installments of 878, 878, 878, and 879 units on June 25, 2026, September 25, 2026, December 25, 2026, and March 25, 2027, respectively.

The awards were received in lieu of cash payments for certain retainer and Board of Director service-related fees under a deferred compensation program for participating non-employee directors. Vested units will be released according to the director’s elected deferral schedule, emphasizing that these are compensation-related equity grants rather than discretionary stock trades.

Positive

  • None.

Negative

  • None.
Insider Michael Edward L.
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Units (Equity Grant) 15,532 $0.00 --
Grant/Award Restricted Stock Units (Converted) 3,513 $0.00 --
Grant/Award Restricted Stock Units (Premium) 1,053 $0.00 --
Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 shares (Direct, null); Restricted Stock Units (Converted) — 3,513 shares (Direct, null); Restricted Stock Units (Premium) — 1,053 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units will vest on June 25, 2027. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. 878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027.
Premium RSU grant 1,053 units Restricted Stock Units (Premium) granted on June 25, 2026
Converted RSU grant 3,513 units Restricted Stock Units (Converted) granted on June 25, 2026
Equity Grant RSUs 15,532 units Restricted Stock Units (Equity Grant) granted on June 25, 2026
Single-date vesting Vests June 25, 2027 One RSU grant vests in full on June 25, 2027
Staggered vesting tranches 878 / 878 / 878 / 879 units Four vesting dates from June 25, 2026 to March 25, 2027
Restricted Stock Units financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred compensation program financial
"under a deferred compensation program applicable to participating non-employee directors."
vesting financial
"878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Michael Edward L.
(Last)(First)(Middle)
9975 SUMMERS RIDGE ROAD
(Street)
SAN DIEGO CALIFORNIA 92121
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (Equity Grant)(1)06/25/2026A15,532 (2) (2)Common Stock15,532$015,532D
Restricted Stock Units (Converted)(1)06/25/2026A3,513 (3)(4) (3)(4)Common Stock3,513$03,513D
Restricted Stock Units (Premium)(1)06/25/2026A1,053 (2)(3) (2)(3)Common Stock1,053$01,053D
Explanation of Responses:
1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
2. The restricted stock units will vest on June 25, 2027.
3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.
4. 878 shares vested on June 25, 2026, 878 shares will vest on September 25, 2026, 878 shares will vest on December 25, 2026, and 879 shares will vest on March 25, 2027.
Remarks:
/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael06/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did QuidelOrtho (QDEL) disclose about Michael Edward L.'s latest Form 4?

QuidelOrtho reported that director Michael Edward L. received several restricted stock unit awards on June 25, 2026. These equity grants compensate him for board service fees and are structured to settle in shares of common stock rather than cash.

How many restricted stock units were granted to the QuidelOrtho (QDEL) director?

The director received three separate restricted stock unit awards of 1,053, 3,513, and 15,532 units. Each unit represents the right to receive one share of QuidelOrtho common stock as the awards vest and are eventually settled.

What are the vesting terms of the new QuidelOrtho (QDEL) restricted stock units?

One restricted stock unit grant vests entirely on June 25, 2027. Another vests in four installments of 878, 878, 878, and 879 units on June 25, 2026, September 25, 2026, December 25, 2026, and March 25, 2027, respectively, before eventual share delivery.

Are the QuidelOrtho (QDEL) restricted stock units open-market purchases or compensation?

These restricted stock units are compensation-related awards, not open-market stock purchases. They were received in lieu of cash retainer and Board of Director service-related fees under a deferred compensation program for participating non-employee directors of QuidelOrtho.

How will the QuidelOrtho (QDEL) director receive shares from these restricted stock units?

Each restricted stock unit entitles the director to one share of QuidelOrtho common stock upon settlement. The release of vested units will follow the director’s elected deferral schedule under the company’s deferred compensation program for non-employee directors.

Does the QuidelOrtho (QDEL) Form 4 show any stock sales by the director?

The Form 4 only reports award-type transactions coded as grants or acquisitions of restricted stock units. There are no reported open-market sales or disposals; all entries relate to equity compensation rather than trading activity by the director.